Optimizing Treatment for Major Depressive Disorder in Adolescents: The Impact of Intradermal Acupuncture - A Randomized Controlled Trial Protocol
- PMID: 37641586
- PMCID: PMC10460602
- DOI: 10.2147/NDT.S420489
Optimizing Treatment for Major Depressive Disorder in Adolescents: The Impact of Intradermal Acupuncture - A Randomized Controlled Trial Protocol
Abstract
Background: Major depressive disorder (MDD) exhibits a pronounced occurrence among adolescents, aligning closely with the lifetime prevalence rate of 16.6% observed in adults. It is difficult to treat and prone to recurrence. Acupuncture has shown potential in enhancing treatment effectiveness. Nonetheless, there is a lack of research on the use of intradermal acupuncture (IA) in treating adolescent MDD.
Methods: This study is a double-blind, randomized controlled trial. A cohort of 120 participants will be assigned randomly to three distinct groups, namely a Selective Serotonin Reuptake Inhibitors (SSRIs)-only group, a sham intradermal acupuncture combined with SSRIs (SIA) group, and an active intradermal acupuncture combined with SSRIs (AIA) group. Hamilton Depression Rating Scale will serve as the primary outcome, while Patient Health Questionnaire-9, Self-Rating Depression Scale, Pittsburgh Sleep Quality Index, and Short Form 36 Questionnaire will serve as secondary outcomes in assessing the amelioration of depressive symptoms in patients. These data will be analyzed using SPSS26.0 software.
Results: We will assess the efficacy and safety of IA for MDD using commonly employed clinical psychiatric scales.
Conclusion: The efficacy of IA in treating adolescent MDD may be demonstrated in this study, suggesting its potential for optimizing MDD treatment schemes.
Trial registration: ClinicalTrials.gov Identifier: NCT05832619 (April 27, 2023).
Keywords: adolescent; intradermal acupuncture; major depressive disorder; protocol; randomized controlled trial; selective serotonin reuptake inhibitors.
© 2023 Chen et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
The efficacy and cerebral mechanism of intradermal acupuncture for major depressive disorder: a multicenter randomized controlled trial.Neuropsychopharmacology. 2025 Jun;50(7):1075-1083. doi: 10.1038/s41386-024-02036-5. Epub 2024 Dec 8. Neuropsychopharmacology. 2025. PMID: 39648209 Free PMC article. Clinical Trial.
-
The efficacy and cerebral mechanism of intradermal acupuncture for major depressive disorder: a study protocol for a randomized controlled trial.Front Psychiatry. 2023 May 15;14:1181947. doi: 10.3389/fpsyt.2023.1181947. eCollection 2023. Front Psychiatry. 2023. PMID: 37255689 Free PMC article.
-
Additional value of auricular intradermal acupuncture alongside selective serotonin reuptake inhibitors: a single-blinded, randomized, sham-controlled preliminary clinical study.Acupunct Med. 2021 Dec;39(6):596-602. doi: 10.1177/0964528421997155. Epub 2021 Mar 3. Acupunct Med. 2021. PMID: 33657871 Clinical Trial.
-
[Use of antidepressant drugs in schizophrenic patients with depression].Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. doi: 10.1016/s0013-7006(06)76153-x. Encephale. 2006. PMID: 16910628 Review. French.
-
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.Biol Psychiatry. 2007 Dec 1;62(11):1217-27. doi: 10.1016/j.biopsych.2007.03.027. Epub 2007 Jun 22. Biol Psychiatry. 2007. PMID: 17588546 Review.
References
-
- Arango C, Buitelaar JK, Fegert JM, et al. Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, Phase 3 trial in nine countries. Lancet Psychiatry. 2022;9(2):113–124. doi:10.1016/S2215-0366(21)00390-4 - DOI - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous